Superstring Capital Management »

Aeglea Biotherapeutics shares owned by Superstring Capital Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Superstring Capital Management from 13F filings

Historical chart of Superstring Capital Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Superstring Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Superstring Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.1M 46k 23.51